Adapt Pharma, Limited has launched a new smartphone app, NARCANÂ® Now, that provides guidance and education for recognizing symptoms of a suspected opioid overdose, a 3-step guide for administering NARCANÂ® (naloxone HCI) Nasal Spray, an instructional video and immediate access to local emergency 911 services.
The app´s simple and easy-to-use design equips those administering NARCANÂ® Nasal Spray with an important new tool that complements the prescribing and patient information. NARCANÂ® Nasal Spray is not a substitute for emergency medical care. See indications and important safety information below.
NARCANÂ® Nasal Spray is the only FDA-approved, ready-to-use naloxone nasal spray that delivers a 4 mg concentrated dose of naloxone in a single spray. NARCANÂ® Nasal Spray is available at a discounted Public Interest Price to qualifying group purchasers including law enforcement, community naloxone distribution programs and first responders. The product has 3rd party insurance coverage. A free carton of NARCANÂ® Nasal Spray is also available for every high school in the United States.
Adapt Pharma is a privately held pharmaceutical company committed to positively impacting the lives of patients. Adapt Pharma´s strategy is to identify, evaluate, selectively acquire and enhance the value of late stage development, and FDA approved, pharmaceutical products. Adapt Pharma´s company headquarters is in Dublin, Ireland and its US headquarters is in Radnor, Pennsylvania.